JP Patent

JP7701366B2 — 脂質代謝異常及び関連状態の治療又は予防におけるアゼライン酸エステル

Assigned to New Frontier Labs LLC · Expires 2025-07-01 · 1y expired

What this patent protects

Patent listed against Recorlev.

Drugs covered by this patent

Recorlev (LEVOKETOCONAZOLE) · Strongbridge

Patent Metadata

Patent number: JP7701366B2
Jurisdiction: JP
Classification: —
Expires: 2025-07-01
Drug substance claim: No
Drug product claim: No
Assignee: New Frontier Labs LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.